In addition, FAS carries the third-highest gene mutational frequency in pan-cancer samples, and FAS mutations have been proven to correlate with cancer development and progression in various tumor types, including malignant glioma [42], breast cancer [43], pulmonary adenocarcinomas [44], and cholangiocarcinoma [45]. This evidence concerns the gene FAS and cholangiocarcinoma.